XML 47 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions and Divestitures (Tables)
 12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed
The allocation of the total purchase price of the 2023 CA Clinics Purchase was as follows:
Property and equipment$313,995 
Operating lease right-of-use asset317,662 
Intangible assets1,004,513 
Total assets acquired1,636,170 
Deferred revenue(158,365)
Operating lease liability - current portion(118,081)
Operating lease liability - net of current portion(199,957)
Net purchase consideration$1,159,767 
Schedule of Discontinued Operations
During the year ended December 31, 2024, certain long-lived assets groups classified as held and used were determined to not be recoverable and were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in (Loss) income from discontinued operations before income tax expense in the consolidated income statement.
Year Ended December 31, 2024
Carrying ValueFair ValueNet loss on disposition or impairment related to discontinued operations
Property and equipment, net$3,971,353 $2,795,190 $1,176,163 
Operating lease right-of-use asset6,483,393 5,014,771 1,468,622 
Intangible assets, net311,074 252,746 58,328 
Total Net loss (income) on disposition or impairment related to discontinued operations$2,703,113 
During the year ended December 31, 2023, certain long-lived asset groups classified as held and used were determined to not be recoverable were written down from their carrying values to their respective fair values resulting in the following non-cash impairment losses which are included in (Loss) income from discontinued operations before income tax expense in the consolidated income statement.
Year Ended December 31, 2023
Carrying ValueFair ValueNet loss on disposition or impairment related to discontinued operations
Property and equipment, net$2,893,779 $1,233,438 $1,660,341 
Operating lease right-of-use asset$80,449 $— $80,449 
Total Net loss (income) on disposition or impairment related to discontinued operations$1,740,790 
As a result of its evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the clinics estimated fair values, the Company recorded an estimated net loss on disposal, which is included in (Loss) income from discontinued operations before income tax expense in the consolidated income statement:
Years Ended
20242023
Net loss (income) on disposition or impairment related to discontinued operations$7,214,565 $657,620 
The following table shows a reconciliation of the Company’s impairment losses and disposal gains and losses recorded in (Loss) income from discontinued operations before income tax expense for the years ended December 31, 2024 and 2023:
Years Ended
20242023
Impairment on long-lived assets held for use
Property and equipment, net$1,176,163 $1,660,341 
Operating lease right-of-use asset1,468,622 80,449 
Intangible assets, net58,328 — 
Impairment on assets held for sale
Assets held for sale7,214,565 657,620 
Loss on disposal of assets other than by sale
Property and equipment, net161,057 255,088 
Operating lease right-of-use asset406,038 — 
Loss (gain) on sale of assets(44,807)— 
Total net loss on disposition or impairment related to discontinued operations$10,439,966 $2,653,498 
The key components of Net (loss) income from discontinued operations that were included in the Company’s consolidated income statements are as follows:
Year Ended December 31,
20242023
Revenues:
Revenues from company-owned or managed clinics$70,249,169 $70,718,879 
Total revenues70,249,169 70,718,879 
Cost of revenues:
IT cost of revenues48,010 65,912 
Total cost of revenues48,010 65,912 
Selling and marketing expenses7,900,884 7,852,327 
Depreciation and amortization3,358,684 7,304,056 
General and administrative expenses55,279,799 55,234,472 
Total selling, general and administrative expenses66,539,367 70,390,855 
Net loss on disposition or impairment from discontinued operations10,439,967 2,653,497 
Loss from discontinued operations(6,778,175)(2,391,385)
Other expense (income), net2,114 (3,776,135)
(Loss) income before income tax expense(6,780,289)1,384,750 
Income tax expense from discontinued operations212,642 367,542 
Net (loss) income from discontinued operations$(6,992,931)$1,017,208 
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in the Company’s consolidated balance sheets:
December 31,
2024		December 31,
2023
ASSETS
Accounts receivable$2,484,248 $1,138,335 
Prepaid expenses and other current assets549,605 595,497 
Assets held for sale36,071,975 17,915,055 
Property and equipment, net208,074 — 
Deferred tax assets (attributable to VIEs)1,087,204 — 
Deposits and other assets425,938 — 
Total current assets, discontinued operations40,827,044 19,648,887 
Property and equipment, net7,238,430 
Operating lease right-of-use asset11,946,953 
Intangible assets, net5,020,926 
Goodwill7,352,879 
Deferred tax assets (attributable to VIEs)1,088,801 
Deposits and other assets494,095 
Total noncurrent assets, discontinued operations
33,142,084 
Total assets, discontinued operations$40,827,044 $52,790,971 
LIABILITIES
Accounts payable$67,107 $371,272 
Accrued expenses5,066,941 805,187 
Payroll liabilities ($0.9 million and $0.7 million attributable to VIEs as of December 31, 2024 and 2023)
2,333,335 2,626,882 
Operating lease liability, current portion153,517 3,343,727 
Finance lease liability, current portion38,015 25,491 
Deferred revenue from company clinics ($0.0 million and $1.6 million attributable to VIEs as of December 31, 2024 and 2023)
— 4,463,747 
Other current liabilities (attributable to VIEs)1,079,441 — 
Liabilities to be disposed of ($5.2 million and $3.6 million attributable to VIEs as of December 31, 2024 and 2023)
28,975,844 13,831,863 
Total current liabilities, discontinued operations37,714,200 25,468,169 
Operating lease liability, net of current portion10,466,689 
Finance lease liability, net of current portion38,016 
Other liabilities, noncurrent (attributable to VIEs)1,235,241 
Total noncurrent liabilities, discontinued operations11,739,946 
Total liabilities, discontinued operations$37,714,200 $37,208,115 
The key components of cash flows from discontinued operations are as follows:
Year Ended December 31,
20242023
Depreciation and amortization3,358,684 7,304,056 
Capital expenditures
Acquisition of CA clinics— 1,188,765 
Purchase of property and equipment664,423 3,857,005 
Significant operating and investing non-cash items
Net loss on disposition or impairment10,439,967 2,653,497 
The principal components of the held for sale assets and liabilities to be disposed of as of December 31, 2024 and December 31, 2023 were as follows:

December 31, 2024December 31, 2023
Assets
Property and equipment, net
$8,497,499 $4,887,220 
Operating lease right-of-use asset19,954,069 9,193,496 
Intangible assets, net6,906,807 3,351,430 
Goodwill8,459,238 1,140,529 
Valuation allowance(7,745,638)(657,620)
Total assets held for sale$36,071,975 $17,915,055 
Liabilities
Operating lease liability, current and non-current$20,873,455 $10,209,382 
Deferred revenue from company clinics8,102,389 3,622,481 
Total liabilities to be disposed of$28,975,844 $13,831,863